
    
      The safety profile of ODM-203 will be explored together with the pharmacokinetics,
      pharmacodynamics and tumour response to treatment with ODM-203 to recommend the dosing
      regimen for further clinical studies. The pharmacokinetic properties of ODM 203 will be
      evaluated after single and multiple dose administrations at different dose levels
    
  